Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychiatr Prax. 1998 Jan;25(1):38-43.

[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)].

[Article in German]

Author information

1
Westfälisches Zentrum für Psychiatrie und Psychotherapie Paderborn, Akademisches Lehrkrankenhaus der Universität Münster.

Abstract

Treatment of patients suffering from schizophrenia is very expensive. However, by consistently and methodically performed medical prophylaxis the disease can be controlled sufficiently well. Regular prophylactic treatment compared to repeated treatment of acute episodes has both medical advantages and reduces cost by reducing the rate of hospitalisation. Prophylactic treatment with Flupentixoldecanoat can save up to 68% of costs.

PMID:
9530768
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center